Company Monitoring Page for Acorda-Therapeutics

latest headlines for company on cafepharma

Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Seeking Alpha
Thu, 04/2/09 - 08:00 am
Tags:
biotech, Acorda Therapeutics, CV Therapeutics, Arena Pharmaceuticals, Genentech, Gilead Sciences, ZymoGenetics, ViroPharma, MAP Pharmaceuticals, Synta, La Jolla Pharmaceutical, Indevus, InterMune, Osiris Therapeutics
FDA and Clinical Trial Updates: Weight Loss, Diabetes and More
Seeking Alpha
Thu, 04/2/09 - 07:26 am
Tags:
Acorda Therapeutics, Arena Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Genentech, GSK, Pfizer, Sepracor, Roche, Wyeth, Orthovita
FDA Won't Review Acorda's MS Drug
TheStreet.com
Tue, 03/31/09 - 08:04 am
Tags:
FDA, MS, multiple sclerosis, Acorda Therapeutics, Fampridine-SR
How to Spend $95 in Biotech
Yahoo/Zacks.com
Wed, 03/18/09 - 06:48 am
Tags:
biotech, Biogen Idec, Acorda Therapeutics, Cypress Bioscience, Isis Pharmaceuticals, Osiris Therapeutics, Genentech, Genzyme, Vertex Pharmaceuticals, Forest Labs, Pozen
Who Will Be America's Next Top Biotech?
TheStreet.com
Mon, 03/16/09 - 10:52 am
Tags:
biotech, Amgen, Genentech, Biogen Idec, Gilead Sciences, Celgene, Acorda Therapeutics, Genzyme, OSI Pharmaceuticals
Behind the Acorda Rumors
Seeking Alpha
Thu, 02/26/09 - 04:25 pm
Tags:
Acorda Therapeutics, Biogen Idec
Should You Be Eyeing Acorda?
Yahoo/Zacks.com
Tue, 02/24/09 - 07:15 pm
Tags:
Acorda Therapeutics, Biogen Idec, Pfizer, Wyeth, Sanofi
9 Possible Pharma Deals for 2009
Seeking Alpha
Thu, 01/8/09 - 05:35 pm
Tags:
Pfizer, Biogen Idec, Amgen, JNJ, Vertex Pharmaceuticals, Bristol-Myers Squibb, Exelis, ViroPharma, Genzyme, Osiris Therapeutics, Forest Labs, Cypress Bioscience, Regeneron, Acorda Therapeutics, OSI Pharmaceuticals, Roche, Genentech

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.